Literatur
TNM-Classification of malignant Tumours, Fifth Edition. Wiley Liss, 1997
International Germ Cell Cancer Collaborative Group: International Germ Cell Cancer Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancer. J Clin Oncol 15: 94–603, 1997
Travis LB, Curtis RE, Storm H, Hall P, Holowaty E, van Leeuwen FE, Kohler BA, Pukkala E, Lynch CF, Anderson M, Bergfeldt K, Clarke EA, Wiklund T, Stoter G, Gospodarowicz M, Sturgeon J, Fraumeni JF, Boice JD (1997) Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89: 1429–1439
Jonker-Pool G, Basten JP van, Hoekstra HJ, Driel MF van, Sleijfer DT, Schraffordt Koops H, Wiel HMB van de (1997) Sexual functioning after treatment for testicular cancer-comparison of treatment modalities. Cancer 80: 454–464
Arai X Kawakita M, Okada Y, Yoshida O (1997) Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 15: 1444–1448
Nuutinen JM, Leskinen S, Elomaa I, Minn H, Varpula M, Solin O, Söderström KO, Joensuu H, Salminen E (1997) Detection of residual tumours in postchemo-therapy testicular cancer by FDG-PET. Eur J Cancer 33: 1234–1241
Pont J, Albrecht W, Postner G, Sellner F, Angel K, Höltl W (1996) Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. J Clin Oncol 14: 441–448
Pont J, Albrecht W (1997) Fertility after chemotherapy for testicular germ cell cancer. Fertil Steril 68: 1–5
Dieckmann KP, Loy V (1996) Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 14: 3126–3132
Herr HW, Sheinfeld J (1997) Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 158: 1331–1334
Weißbach L (1995) Organ preserving surgery of malignant germ cell tumors. J Urol 153: 90–93
Heidenreich A, Hoeltl W, Albrecht W, Pont J, Engelmann UH (1997) Testis-preserving surgery in bilateral testicular germ cell tumours. Br J Urol 79: 253–257
Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP (1997) Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15: 239–245
Fossa SD, Oliver RTD, Stenning SP, Horwich A, Wilkinson P, Read G, Mead GM, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook P (1997) Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer 33: 1380–1387
Stephens AW, Gonin R, Hutchins GD, Einhorn LH (1996) Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 14: 1637–1641
Warde P, Gospodarowicz M, Panzarella T, Catton CN, Stureon JFG, Moore M, Goodman P, Jewett MAS (1995) Stage I testicular seminoma: results of adjuvant irradiation and surveillance, J Clin Oncol 13: 2255–2262
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Höltl, W. Was gibt es Neues in der Therapie von Hodentumoren?. Der Urologe B 38, S18–S21 (1998). https://doi.org/10.1007/s001310050365
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001310050365